Treatment Approach for Patients with Irritable Bowel Syndrome and Mood Disorders

Pharmacological Management

The American Gastroenterological Association recommends SSRIs at therapeutic doses as first-line treatment for patients with IBS and co-occurring depression or anxiety, as they can effectively address both psychological symptoms and gastrointestinal complaints simultaneously 1, 2
For patients with IBS and predominant abdominal pain without significant mood disorders, low-dose tricyclic antidepressants (TCAs) should be considered first-line, initiated at low doses and titrated according to symptomatic response 2, 3
Augmentation with both an SSRI and a low-dose TCA may be beneficial for patients with severe symptoms who don't respond to monotherapy, though this approach requires careful monitoring for adverse events 4
Selective noradrenaline reuptake inhibitors (SNRIs) could be useful alternatives for patients with IBS and psychological comorbidity, though evidence from randomized controlled trials is limited 3

Standard dietary advice should be provided first for patients with mild gastrointestinal symptoms and co-occurring mood disorders 5
A Mediterranean diet may benefit both gut and mental health for patients with substantial psychological symptoms 1, 4
A "gentle" FODMAP approach is recommended rather than a strict low FODMAP diet for patients with moderate to severe gastrointestinal symptoms alongside mood disorders 1, 6
Dietary counseling should be patient-centered and tailored to the individual, considering nutrition status, severity of physical and mental comorbidities, and psychosocial factors 1
A strict low FODMAP diet should be avoided in patients with severe mental illness or eating pathology, as it may exacerbate psychological symptoms 1, 5

Brain-gut behavioral therapies (BGBTs) such as cognitive behavioral therapy, gut-directed hypnotherapy, and mindfulness-based stress reduction are recommended for patients with IBS and mood disorders 1
Self-management approaches including education and lifestyle modifications should be implemented for patients with low severity of psychological symptoms 1
Traditional psychological treatments should complement brain-gut behavioral therapies for patients with moderate to severe psychological symptoms 4
Self-management resources can provide strategies to modify lifestyle factors known to contribute to IBS symptoms, such as physical activity, sleep hygiene, and mindful eating 1

An integrated care model that includes medical management, dietary modifications, and psychological therapy delivered by a multidisciplinary team is considered best practice for managing IBS with comorbid mood disorders 8, 9
Clinicians should master patient-friendly language for discussion of the gut-brain axis and how depression or anxiety can lead to the onset, perpetuation, and/or maintenance of IBS, and vice versa 6
Referral thresholds should be established for specialist care, including gastroenterologists, dietitians, and psychologists 6
All clinicians involved should assure patients they will remain engaged in their care and work with other practitioners to ensure holistic treatment 1

Avoid using low-dose TCAs as monotherapy in patients with established mood disorders, as these doses are insufficient for treating psychological symptoms 2, 3

Regular assessment of both gastrointestinal and psychological symptoms is essential to evaluate treatment response 6
Adjust the duration and/or frequency of assessment and treatment visits to accommodate mental health needs and ongoing monitoring 6
If psychological symptoms worsen during treatment, promptly inform the patient's referring doctor, general practitioner, or mental health provider, particularly if there is risk of self-harm 6
Periodically reassess the need for continued therapy and adjust treatment strategies based on symptom evolution 1